VIVJOA
NDC 74695-823, oteseconazole, capsule, from Mycovia Pharmaceuticals, Inc..
- Product NDC
- 74695-823
- Status
- Listed
- Labeler
- Mycovia Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215888
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/74695-823 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OTESECONAZOLE150 mg/1
Pharmacologic classes
Azole Antifungal [EPC]; Azoles [CS]; Breast Cancer Resistance Protein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 74695-823-18 | 74695082318 | 1 CONTAINER in 1 CARTON (74695-823-18) / 1 BLISTER PACK in 1 CONTAINER / 18 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e21d5008-800e-4417-927f-14340341865f
Use it
Look up 74695-823 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/74695-823 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 74695-823. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.